» Articles » PMID: 38266676

Thrombomodulin: a Multifunctional Receptor Modulating the Endothelial Quiescence

Overview
Publisher Elsevier
Specialty Hematology
Date 2024 Jan 24
PMID 38266676
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombomodulin (TM) is a type 1 receptor best known for its function as an anticoagulant cofactor for thrombin activation of protein C on the surface of vascular endothelial cells. In addition to its anticoagulant cofactor function, TM also regulates fibrinolysis, complement, and inflammatory pathways. TM is a multidomain receptor protein with a lectin-like domain at its N-terminus that has been shown to exhibit direct anti-inflammatory functions. This domain is followed by 6 epidermal growth factor-like domains that support the interaction of TM with thrombin. The interaction inhibits the procoagulant function of thrombin and enables the protease to regulate the anticoagulant and fibrinolytic pathways by activating protein C and thrombin-activatable fibrinolysis inhibitor. TM has a Thr/Ser-rich region immediately above the membrane surface that harbors chondroitin sulfate glycosaminoglycans, and this region is followed by a single-spanning transmembrane and a C-terminal cytoplasmic domain. The structure and physiological function of the extracellular domains of TM have been extensively studied, and numerous excellent review articles have been published. However, the physiological function of the cytoplasmic domain of TM has remained poorly understood. Recent data from our laboratory suggest that intracellular signaling by the cytoplasmic domain of TM plays key roles in maintaining quiescence by modulating phosphatase and tensin homolog signaling in endothelial cells. This article briefly reviews the structure and function of extracellular domains of TM and focuses on the mechanism and possible physiological importance of the cytoplasmic domain of TM in modulating phosphatase and tensin homolog signaling in endothelial cells.

Citing Articles

Statin Therapy before Percutaneous Coronary Intervention: A Novel Bridge between Thrombin and Thrombomodulin for Enhanced Cardiovascular Protection.

Wang Z, Lai B, Shi X, Wang X, Fang X, Wei Y ACS Omega. 2025; 10(6):6056-6063.

PMID: 39989830 PMC: 11840598. DOI: 10.1021/acsomega.4c10348.


Multicenter Prospective Pilot Study Identifying Thrombomodulin as a Potential Biomarker for Neurocognitive Outcomes in Immune Thrombotic Thrombocytopenic Purpura.

Boothby A, Evans M, Yang S, Sukumar S, Scott J, Terrell D J Clin Med. 2025; 14(3).

PMID: 39941363 PMC: 11818605. DOI: 10.3390/jcm14030694.


Disseminated intravascular coagulation: cause, molecular mechanism, diagnosis, and therapy.

Gong F, Zheng X, Zhao S, Liu H, Chen E, Xie R MedComm (2020). 2025; 6(2):e70058.

PMID: 39822757 PMC: 11733103. DOI: 10.1002/mco2.70058.


Understanding Cardiovascular Events With JAK Inhibitors: Tofacitinib Reduces Synovial and Vascular Inflammation but not the Prothrombotic Effects of Inflammatory Cytokines on Endothelium.

Zavoriti A, Miossec P ACR Open Rheumatol. 2025; 7(1):e11790.

PMID: 39800890 PMC: 11725533. DOI: 10.1002/acr2.11790.

References
1.
Wu C, Kim P, Swystun L, Liaw P, Weitz J . Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells. J Thromb Haemost. 2015; 14(2):366-74. DOI: 10.1111/jth.13222. View

2.
Ma C, Chang W, Shi G, Chang B, Cheng S, Shih Y . Recombinant thrombomodulin inhibits lipopolysaccharide-induced inflammatory response by blocking the functions of CD14. J Immunol. 2015; 194(4):1905-15. DOI: 10.4049/jimmunol.1400923. View

3.
Loghmani H, Conway E . Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018; 132(2):148-158. DOI: 10.1182/blood-2017-12-768994. View

4.
Hsu Y, Shi G, Kuo C, Liu S, Wu C, Ma C . Thrombomodulin is an ezrin-interacting protein that controls epithelial morphology and promotes collective cell migration. FASEB J. 2012; 26(8):3440-52. DOI: 10.1096/fj.12-204917. View

5.
Raife T, Lager D, Madison K, Piette W, Howard E, Sturm M . Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J Clin Invest. 1994; 93(4):1846-51. PMC: 294263. DOI: 10.1172/JCI117171. View